Every Cure set to get up to $76M from ARPA-H to test its AI picks (opens the source in a new tab)
- A three-year phase from 2026 moves AI-picked ideas toward patients.
- It builds on an earlier $48.3M ARPA-H contract that built the MATRIX platform.
- 20+
- ideas for preclinical tests
- 10
- clinical trials enabled
Why it matters US public money is betting on AI-found cures.
Other side AI predictions still have to survive trials; most drug candidates don’t.
Source:Every Cure (free to read) ↗